These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Laryngeal mucous membrane pemphigoid serves as a prognostic factor for poor response to treatment with rituximab. Baniel A; Oestreicher-Kedem Y; Peled A; Bar-Ilan E; Geller S; Sprecher E; Baum S Clin Exp Dermatol; 2021 Jul; 46(5):915-919. PubMed ID: 33811681 [TBL] [Abstract][Full Text] [Related]
11. Rituximab combined with conventional therapy versus conventional therapy alone for the treatment of mucous membrane pemphigoid (MMP). Maley A; Warren M; Haberman I; Swerlick R; Kharod-Dholakia B; Feldman R J Am Acad Dermatol; 2016 May; 74(5):835-40. PubMed ID: 26936298 [TBL] [Abstract][Full Text] [Related]
12. [Rituximab use in mucous membrane pemphigoid]. Bertrand AS; Dereure O; Girard C; Bessis D; Guillot B Ann Dermatol Venereol; 2019 Oct; 146(10):659-661. PubMed ID: 31358309 [No Abstract] [Full Text] [Related]
13. Mucous membrane pemphigoid with antibodies to the beta(3) subunit of Laminin 332 in a patient with acute myeloblastic leukemia and graft-versus-host disease. Takahara M; Tsuji G; Ishii N; Dainichi T; Hashimoto T; Kohno K; Kamezaki K; Nagafuji K; Takeuchi S; Moroi Y; Furue M Dermatology; 2009; 219(4):361-4. PubMed ID: 19797892 [No Abstract] [Full Text] [Related]
14. Development of mucous membrane pemphigoid with antibodies to the β3 subunit of laminin 332 and bronchiolitis obliterans in a patient with chronic graft-versus-host disease. Okada R; Yamaguchi Y; Sawaki H; Hashimoto T; Aihara M Eur J Dermatol; 2015; 25(5):505-6. PubMed ID: 26243509 [No Abstract] [Full Text] [Related]
15. Antiepiligrin cicatricial pemphigoid with autoantibodies to the beta subunit of laminin 5 and associated with severe laryngeal involvement necessitating tracheostomy. Seo SH; Kye YC; Kim SN; Kim SC Dermatology; 2001; 202(1):63-6. PubMed ID: 11244234 [TBL] [Abstract][Full Text] [Related]
16. Rituximab for the Treatment of Isolated Refractory Desquamative Gingivitis Due to Mucous Membrane Pemphigoid. Haefliger S; Horn MP; Suter VG; Bornstein MM; Borradori L JAMA Dermatol; 2016 Dec; 152(12):1396-1398. PubMed ID: 27732708 [No Abstract] [Full Text] [Related]
17. Intravenous immunoglobulins for rituximab-resistant mucous membrane pemphigoid. Witte M; Zillikens D; Shimanovich I J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):e321-e324. PubMed ID: 29443427 [No Abstract] [Full Text] [Related]